ABO DIAG has been acquired by DIAGAST
The private shareholders and investment funds Succes Eur. and Aqui Invest, based in France, have sold ABO DIAG to DIAGAST for US$6.5 million.
ABO DIAG was founded in 2008 by its CEO, Najim Chaibi. Located in the technopolis of Montesquieu, the company is based on the research and development of diagnostic devices dedicated to blood transfusion and more widely to immuno-haematology. ABO DIAG is a pioneer in the field of research of new solutions for haematological diagnosis. The company's patent protected technology is based on immunological detection in vertical flow with colored dots. This innovation provides higher sensibility and higher safety in diagnosis, thanks to a simple user procedure and with standardized results. ABO DIAG was awarded the First Prize of Innovation at JIB 2012 (Innovation of the year in Biology).
DIAGAST is the worldwide leader in the marketing and development of reagents and instrumentation systems that aim to ensure donor and patient compatibility during blood transfusions. Over the last 30 years, the company has developed unparalleled expertise and know-how in the transfusion sector.
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
Related deals
iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn moreLargest AIM IPO in the business support services sector over the past five years has been completed
MHA plc raised US$131 million (£98 million) through a placing and retail offer, achieving a market capitalization of approximately US$363 million (£271 million) on admission. This was the largest AIM IPO in the business support services sector over the past five years. The IPO provides a platform for continued investment in technology, talent and acquisitions, supporting the group’s ambition to become a top 10 UK professional services firm.
Learn moreChequers Capital has acquired Gourmet Italian Food to strengthen presence in the ready meals sector
Chequers Partenaires S.A., acting as the management company of the private equity fund Chequers Capital XVIII SLP, together with management, has completed the acquisition of 100% of the share capital of Gourmet Italian Food S.p.A. (GIF). The company was previously owned by Alcedo SGR S.p.A. through the Alcedo IV Fund, FVS SGR S.p.A. through the Sviluppo PMI Fund, and minority shareholders.
Learn more